Žaidimo vietos santrauka
| States | Namų rungtynės | Išvykos rungtynės |
|---|---|---|
| MIN | 30:00 | 46:00 |
| 2P M/A |
54.5%
6/11
|
55.6%
5/9
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
66.7%
4/6
|
100%
2/2
|
| REB |
14
9/5
|
5
4/1
|
| AS | 3 | 5 |
| ST | 0 | 3 |
| TO | 1 | 0 |
| BS | 1 | 1 |
| PF | 4 | 4 |
| PTS | 16 | 12 |
| EFF | 26 | 22 |
| GM | 1 | 2 |
| States | Namų rungtynės | Išvykos rungtynės |
|---|---|---|
| MIN | 30:00 | 23:00 |
| 2P M/A |
54.5%
6/11
|
55.6%
5/9
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
66.7%
4/6
|
100%
2/2
|
| REB |
14
9/5
|
2.5
2/0.5
|
| AS | 3 | 2.5 |
| ST | 0 | 1.5 |
| TO | 1 | 0 |
| BS | 1 | 0.5 |
| PF | 4 | 2 |
| PTS | 16 | 6 |
| EFF | 26 | 11 |
| GM | 1 | 2 |
Žaidimo rezultatų santrauka
| States | Pralaimėjimai |
|---|---|
| MIN | 76:00 |
| 2P M/A |
55%
11/20
|
| 3P M/A |
0%
0/0
|
| FT M/A |
75%
6/8
|
| REB |
19
13/6
|
| AS | 8 |
| ST | 3 |
| TO | 1 |
| BS | 2 |
| PF | 8 |
| PTS | 28 |
| EFF | 48 |
| GM | 3 |
| States | Pralaimėjimai |
|---|---|
| MIN | 25:18 |
| 2P M/A |
55%
11/20
|
| 3P M/A |
0%
0/0
|
| FT M/A |
75%
6/8
|
| REB |
6.3
4.3/2
|
| AS | 2.7 |
| ST | 1 |
| TO | 0.3 |
| BS | 0.7 |
| PF | 2.7 |
| PTS | 9.3 |
| EFF | 16 |
| GM | 3 |
Naujausi žaidimo rezultatai
| States | Paskutinės 5 rungtynės | Last 10 games |
|---|---|---|
| MIN | 76:00 | 76:00 |
| 2P M/A |
55%
11/20
|
55%
11/20
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
75%
6/8
|
| REB |
19
13/6
|
19
13/6
|
| AS | 8 | 8 |
| ST | 3 | 3 |
| TO | 1 | 1 |
| BS | 2 | 2 |
| PF | 8 | 8 |
| PTS | 28 | 28 |
| EFF | 48 | 48 |
| GM | 3 | 3 |
| States | Paskutinės 5 rungtynės | Last 10 games |
|---|---|---|
| MIN | 25:18 | 25:18 |
| 2P M/A |
55%
11/20
|
55%
11/20
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
75%
6/8
|
| REB |
6.3
4.3/2
|
6.3
4.3/2
|
| AS | 2.7 | 2.7 |
| ST | 1 | 1 |
| TO | 0.3 | 0.3 |
| BS | 0.7 | 0.7 |
| PF | 2.7 | 2.7 |
| PTS | 9.3 | 9.3 |
| EFF | 16 | 16 |
| GM | 3 | 3 |
Mėnesinė ir priešininkų analizė
| States | Suminiai | Rugsėjis |
|---|---|---|
| MIN | 76:00 | 76:00 |
| 2P M/A |
55%
11/20
|
55%
11/20
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
75%
6/8
|
| REB |
19
13/6
|
19
13/6
|
| AS | 8 | 8 |
| ST | 3 | 3 |
| TO | 1 | 1 |
| BS | 2 | 2 |
| PF | 8 | 8 |
| PTS | 28 | 28 |
| EFF | 48 | 48 |
| GM | 3 | 3 |
| States | Suminiai | Rugsėjis |
|---|---|---|
| MIN | 25:18 | 25:18 |
| 2P M/A |
55%
11/20
|
55%
11/20
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
75%
6/8
|
| REB |
6.3
4.3/2
|
6.3
4.3/2
|
| AS | 2.7 | 2.7 |
| ST | 1 | 1 |
| TO | 0.3 | 0.3 |
| BS | 0.7 | 0.7 |
| PF | 2.7 | 2.7 |
| PTS | 9.3 | 9.3 |
| EFF | 16 | 16 |
| GM | 3 | 3 |
| States | Suminiai | Tianjin Pioneers |
|---|---|---|
| MIN | 76:00 | 30:00 |
| 2P M/A |
55%
11/20
|
54.5%
6/11
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
66.7%
4/6
|
| REB |
19
13/6
|
14
9/5
|
| AS | 8 | 3 |
| ST | 3 | 0 |
| TO | 1 | 1 |
| BS | 2 | 1 |
| PF | 8 | 4 |
| PTS | 28 | 16 |
| EFF | 48 | 26 |
| GM | 3 | 1 |
| States | Suminiai | Tianjin Pioneers |
|---|---|---|
| MIN | 25:18 | 30:00 |
| 2P M/A |
55%
11/20
|
54.5%
6/11
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
66.7%
4/6
|
| REB |
6.3
4.3/2
|
14
9/5
|
| AS | 2.7 | 3 |
| ST | 1 | 0 |
| TO | 0.3 | 1 |
| BS | 0.7 | 1 |
| PF | 2.7 | 4 |
| PTS | 9.3 | 16 |
| EFF | 16 | 26 |
| GM | 3 | 1 |
| States | Suminiai | Shandong Hi-Speed |
|---|---|---|
| MIN | 76:00 | 25:00 |
| 2P M/A |
55%
11/20
|
100%
4/4
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
100%
2/2
|
| REB |
19
13/6
|
2
1/1
|
| AS | 8 | 1 |
| ST | 3 | 2 |
| TO | 1 | 0 |
| BS | 2 | 0 |
| PF | 8 | 2 |
| PTS | 28 | 10 |
| EFF | 48 | 15 |
| GM | 3 | 1 |
| States | Suminiai | Shandong Hi-Speed |
|---|---|---|
| MIN | 25:18 | 25:00 |
| 2P M/A |
55%
11/20
|
100%
4/4
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
100%
2/2
|
| REB |
6.3
4.3/2
|
2
1/1
|
| AS | 2.7 | 1 |
| ST | 1 | 2 |
| TO | 0.3 | 0 |
| BS | 0.7 | 0 |
| PF | 2.7 | 2 |
| PTS | 9.3 | 10 |
| EFF | 16 | 15 |
| GM | 3 | 1 |
| States | Suminiai | Qingdao Guoxin Pharmaceutical |
|---|---|---|
| MIN | 76:00 | 21:00 |
| 2P M/A |
55%
11/20
|
20%
1/5
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
0%
0/0
|
| REB |
19
13/6
|
3
3/0
|
| AS | 8 | 4 |
| ST | 3 | 1 |
| TO | 1 | 0 |
| BS | 2 | 1 |
| PF | 8 | 2 |
| PTS | 28 | 2 |
| EFF | 48 | 7 |
| GM | 3 | 1 |
| States | Suminiai | Qingdao Guoxin Pharmaceutical |
|---|---|---|
| MIN | 25:18 | 21:00 |
| 2P M/A |
55%
11/20
|
20%
1/5
|
| 3P M/A |
0%
0/0
|
0%
0/0
|
| FT M/A |
75%
6/8
|
0%
0/0
|
| REB |
6.3
4.3/2
|
3
3/0
|
| AS | 2.7 | 4 |
| ST | 1 | 1 |
| TO | 0.3 | 0 |
| BS | 0.7 | 1 |
| PF | 2.7 | 2 |
| PTS | 9.3 | 2 |
| EFF | 16 | 7 |
| GM | 3 | 1 |